SDH
Sloy Dahl & Holst’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,353
| Closed | -$460K | – | 88 |
|
|
2023
Q4 | $460K | Buy |
7,353
+723
| +11% | +$45.3K | 0.09% | 52 |
|
|
2023
Q3 | $301K | Hold |
6,630
| – | – | 0.07% | 63 |
|
|
2023
Q2 | $372K | Hold |
6,630
| – | – | 0.07% | 54 |
|
|
2023
Q1 | $300K | Hold |
6,630
| – | – | 0.07% | 50 |
|
|
2022
Q4 | $270K | Hold |
6,630
| – | – | 0.09% | 53 |
|
|
2022
Q3 | $433K | Hold |
6,630
| – | – | 0.09% | 42 |
|
|
2022
Q2 | $403K | Hold |
6,630
| – | – | 0.1% | 45 |
|
|
2022
Q1 | $416K | Buy |
+6,630
| New | +$416K | 0.07% | 46 |
|
|
2021
Q3 | – | Sell |
-33,376
| Closed | -$5.4M | – | 93 |
|
|
2021
Q2 | $5.4M | Buy |
33,376
+6,213
| +23% | +$1.01M | 0.73% | 16 |
|
|
2021
Q1 | $3.31M | Buy |
+27,163
| New | +$3.31M | 0.47% | 17 |
|